Net Loss Per Share (Tables)

9 Months Ended

Sep. 30, 2020

Earnings Per Share [Abstract]

Schedule of Outstanding Potentially Dilutive Common Stock Equivalents Excluded from Calculation of Diluted Net Loss Per Share

The Company did not have any anti-dilutive common stock equivalents for the three and nine months ended September 30, 2020 and for the three months ended September 30, 2019. The following outstanding potentially dilutive common stock equivalents have been excluded from the calculation of diluted net loss per share for the period presented due to their anti-dilutive effect:

	Nine Months Ended September 30, 2019
Convertible preferred stock		31,968,570
Common stock options		3,833,299
RSUs		2,867,326
Restricted stock subject to future vesting		481,698
Convertible preferred stock warrants		256,588
Common stock warrants		27,810
		39,435,291